The Biden administration is out to break the law. It’s proposed a framework for federal agencies to impose “march-in” rights on patented inventions that stem from federally funded research.
Draft interagency guidance pushes novel policy—basing march-in on the price of a product related to a university’s or small business’s patent tied to federal research dollars. Nothing in the Bayh-Dole Act of 1980 authorizes such a consideration.
Comments